CERA

Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

Unwrap sight-saving discoveries

This festive season, support CERA’s research into cutting edge technologies and help put hope in sight for people with vision loss and blindness.

Video

Watch Professor Robyn Guymer AM, Associate Professor Lyndell Lim and Associate Professor Peter van Wijngaarden discuss the latest in vision research.

EYE HEALTH RESOURCES

Our free guide gives you an essential introduction to age-related macular degeneration (AMD), and a snapshot of the latest research conducted at CERA.

Video

In this video, learn about CERA’s research into gene therapies that could halt or even reverse vision loss in patients with conditions such as inherited retinal diseases and glaucoma.

Donate to CERA

With your support, there’s hope in sight.

Your gift will contribute to our world-leading vision research, making a real difference to people affected by vision loss and blindness.

Donate now

Take part in research

We conduct world-leading clinical trials for a range of eye conditions.

Learn more about taking part in clinical trials for conditions like age-related macular degeneration, glaucoma, diabetic retinopathy and more.

Learn more

Latest News


News

08 December 2022

Three new, innovative ideas have received a boost from CERA’s Innovation Fund.

News

18 November 2022

From ground-breaking glaucoma research at CERA to a recent media residency at the ABC, Dr Flora Hui is now taking her next steps to inspire the next generation of STEM.

Research

09 November 2022

Itchy eyes can be caused by many different things, but rubbing them for relief can be linked to keratoconus.

Research

03 October 2022

Australians with inherited retinal disease (IRD) have a strong interest in undergoing gene therapy to prevent and treat blindness – but there’s a critical need for education programs to help them make informed choices about future treatments.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals